Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
GeneDx Holdings Corp. (WGS) had Consolidated Net Income/Loss of $-7.63M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$116.74M |
|
$-7.63M |
|
$32.22M |
|
$84.53M |
|
$119.99M |
|
$-3.25M |
|
$-4.14M |
|
$-7.39M |
|
$-7.39M |
|
$-7.63M |
|
$-7.63M |
|
|
Consolidated Net Income/Loss |
$-7.63M |
$-7.63M |
|
$-3.25M |
|
$3.22M |
|
28.80M |
|
28.80M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$237.58M |
|
$42.42M |
|
$256.32M |
|
$493.90M |
|
$87.62M |
|
$51.58M |
|
$114.02M |
|
$201.64M |
|
$292.26M |
|
$106.88M |
|
$292.26M |
|
28.89M |
|
| Cash Flow Statement Financials | |
$36.37M |
|
$-50.45M |
|
$24.83M |
|
$86.20M |
|
$96.96M |
|
$10.76M |
|
$22.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.71 |
|
-- |
|
-- |
|
0.15 |
|
0.18 |
|
72.40% |
|
-2.78% |
|
-2.78% |
|
-- |
|
-6.33% |
|
-6.54% |
|
$21.70M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
3.05 |
|
1.92 |
|
46.98 |
|
-2.61% |
|
-7.14% |
|
-1.55% |
|
-2.22% |
|
$10.12 |
|
$0.75 |
|
$1.26 |
|